Omnicell
Nnamdi Njoku currently serves as the EVP & Chief Operating Officer at Omnicell, overseeing global operations and continuous improvement initiatives, which encompass customer experience, engineering, quality, supply chain, sales, and specialized business units. Prior to joining Omnicell, Nnamdi held the position of President at Zimmer Biomet, leading multiple divisions within sports medicine and surgical therapies. From 2005 to March 2023, Nnamdi held various senior leadership roles at Medtronic, including President of the Neuromodulation Operating Unit and the Mechanical Circulatory Support unit, contributing to significant portfolio growth and operational excellence. Nnamdi's early career included roles at UnitedHealth Group and Deloitte Consulting, following a strong educational background that includes an MBA from Cornell University and a BA from the University of St. Thomas.
This person is not in any teams
This person is not in any offices
Omnicell
26 followers
Since 1992, Omnicell (NASDAQ: OMCL) has been transforming the pharmacy care delivery model through the Autonomous Pharmacy, a combination of hardware, software, and services that enables providers to improve quality, reduce costs, and increase human efficiencies. Through Omnicell’s industry-leading medication management platform and portfolio of technology-enabled services, health systems and retail pharmacies are realizing how connected technology and intelligence can help solve for the most pressing challenges in medication management.